natgillin/translations-raw huggingface dataset:
Before removing the syringe from the vial, withdraw a volume of gas from above the solution equal to the volume of pertechnetate added in order to normalise the pressure inside the vial.
Preden odstranite brizgo iz viale, izvlecite enak volumen plina nad raztopino, kot je volumen dodanega pertehnetata, da normalizirate tlak v viali.
Your doctor may recommend that you drink plenty of fluids to speed removal of traces of the radiopharmaceutical from your body.
Zdravnik vam lahko priporoči pitje velikih količin tekočine za pospešitev odstranjevanja sledov radiofarmacevtskega
Studies in healthy volunteers have demonstrated that the tracer confers three-compartment pharmacokinetic characteristics with a distribution half-life of less than 5 minutes and a terminal halflife of about 20 hours, and a steady-state volume of distribution of 1.5 to 3 l/kg.
Študije z zdravimi prostovoljci so dokazale, da označevalec daje tridelne farmakokinetične značilnosti s porazdelitvenim razpolovnim časom manj kot 5 minut in končnim razpolovnim časom približno 20 ur, ter volumnom porazdelitve v dinamičnem ravnotežju (“steady state”) 1,5 do 3 l/kg.
Appropriate aseptic precautions should be taken, complying with the requirements of Good Manufacturing Practice (GMP) for pharmaceuticals.
Glede aseptičnosti se mora izvajati ustrezne previdnostne ukrepe v sladu z Dobro proizvodno prakso (GMP) za zdravila.
NeoSpect is a radiopharmaceutical product used for diagnostic purposes.
NeoSpect je radiofarmacevtski izdelek, ki se uporablja za diagnostične namene.
For this product, the effective dose resulting from an administered activity of 555-740 MBq is typically 8.88-11.84 mSv for a 70 kg individual.
Pri tem zdravilu, je učinkovita doza po dajanju 555-740 MBq aktivnosti, tipično 8,88-11,84 mSv za 70 kg težko osebo.
Care should be exercised in patients with impaired renal function, due to lower renal excretion and probable increase in exposure to radioactivity.
Previdnost je potrebna pri bolnikih z okvarjeno ledvično funkcijo, zaradi slabšega ledvičnega izločanja in verjetnega povečanja izpostavljenosti sevanju.
If overdose is suspected, symptomatic treatment will be administered.
Kadar se sumi na prevelik odmerek, se uvede simptomatsko zdravljenje.
The negative predictive value was 87.5% (CI 66.5-96.7%) for all lesions and 87.5% for lesions equal to or less than 3cm.
Negativna napovedna vrednost je bila 87,5% (IZ 66,5-96,7 %) za vse lezije in 87,5% za lezije enake ali manjše od 3 cm.
However, histology was predominantly obtained by fine needle aspiration (FNA) with 5 out of 49 patients having open thoracotomies.
Vendar pa so vzorce za histologijo dobili predvsem z aspiracijsko biopsijo s tanko iglo (FNA), 5 od 49 bolnikov je imelo odprto torakotomijo.
NeoSpect is a powder for solution for injection that has to be dissolved and labelled with radioactive technetium before use.
NeoSpect je prašek za raztopino za injiciranje, ki ga moramo pred uporabo raztopiti in označiti z radioaktivnim tehnecijem.
For diagnostic nuclear medicine investigations, the current evidence suggests that these adverse events will occur with low frequency because of the low radiation doses incurred.
Dosedanji podatki za preiskave v diagnostični nuklearni medicini nakazujejo, da se bodo ti neželeni dogodki pojavljali zelo redko, zaradi nizkih doz sevanja.
Technetium-99m disintegrates by isomeric transition with the emission of gamma radiation with an energy of 140 keV and a half life of 6 hours to technetium-99, which can be regarded as quasi stable.
Tehnecij-99m razpada z izomeričnim prehodom z emisijo gama sevanja z energijo 140 keV in razpolovnim časom 6 ur v tehnecij-99, ki ga lahko štejemo za skoraj stabilnega.
In the absence of incompatibility studies, 99mTc-depreotide must not be mixed with other medicinal products.
Zaradi pomankanja študij kompatibilnosti, 99mTc-depreotida ne smemo mešati z drugimi zdravili.
The medicinal product is for hospital use or in designated Nuclear Medicine Facilities only, by persons experienced in radioisotope diagnostic imaging.
Zdravilo je namenjeno samo za uporabo v bolnišnicah ali v pooblaščenih enotah za nuklearno medicino, z osebjem izkušenim za radioizotopsko diagnostično slikanje.
Therapy with octreotide acetate can produce severe hypoglycaemia in patients with insulinomas, and other somatostatin analogues are known to impair glucose tolerance.
Zdravljenje z oktreotid acetatom lahko povzroči pri bolnikih z insulinomom hudo hipoglikemijo in znano je da drugi analogi somatostatina zmanjšajo glukozno toleranco.
A diagnostic radiopharmaceutical is a product which, when injected, temporarily collects in a particular part of the body (for example a tumour).
Diagnostični radiofarmacevtski izdelek je izdelek, ki se po injiciranju začasno nakopiči v določenem delu telesa (n.pr.
Renal clearance averaged about 0.3 ml/min/kg.
Ledvični očistek je bil povprečno 0,3 ml/min/kg.
Add more distilled water or sodium chloride as needed for subsequent use always maintaining some undissolved sodium chloride at the bottom of the chamber.)
Za ponovno uporabo dodajte po potrebi še destilirane vode ali natrijevega klorida, tako da vedno ostane nekaj neraztopljenega natrijevega klorida na dnu komore.)
Exposure to ionising radiation is linked with cancer induction and a potential for development of hereditary defects.
Izpostavljanje ionizirajočem sevanju je povezano z nastankom raka in možnostjo razvoja genetskih okvar.
Do not allow the spots to dry.
Pazite, da se nanešene kapljice ne posušijo.
In a clinical study examining the pharmacodynamic effects of the recommended dose of the peptide in human volunteers during an oral GTT (Glucose Tolerance Test), no effects were observed other than the normal physiologic response to oral glucose challenge.
V klinični študiji s prostovoljci, s katero so raziskovali farmakodinamične učinke priporočenega odmerka peptida med peroralnim GTT (glukozni tolerančni test), niso opazili nobenega učinka, razen normalnega fiziološkega odziva na obremenitev z glukozo.
Parenteral medicinal products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit: visually inspect the reconstituted solution at a safe distance through leaded glass.
Zdravila za parenteralno uporabo moramo pred uporabo vizuelno pregledati na prisotnost delcev in spremembo barve, kadarkoli to raztopina in vsebnik dopuščata: vizuelno preglejte rekonstituirano raztopino iz varne razdalje skozi svinčeno steklo.
There is only limited data available regarding interactions with other products.
O medsebojnem delovanju z drugimi zdravili so na voljo le omejeni podatki.
Do not use NeoSpect after the expiry date which is stated on the label.
Zdravila NeoSpect ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na ovojnini.
99mTc-depreotide binds to the extent of about 12% to plasma proteins in patients and healthy
99mTc-depreotid se veže na plazemske proteine v obsegu do približno 12% pri bolnikih in zdravih
External whole-body gamma scintigraphy showed highest location of radioactivity in the abdomen.
Eksterna gama scintigrafija celotnega telesa je pokazala največjo radioaktivnost v predelu trebuha.
99mTc-depreotide, must be handled with care, and appropriate safety measures should be used to minimise radiation exposure to clinical personnel.
Z 99mTc-depretoidom se mora ravnati previdno in uporabljati se mora ustrezne varnostne ukrepe za zmanjševanje izpostavljenosti kliničnega osebja sevanju.
Based on human data, the absorbed radiation doses by individual organs of an average human adult (70 kg) from an intravenous injection of the agent are listed below.
Na podlagi podatkov pri človeku, so spodaj navedene absorbirane doze sevanja za posamezne organe po intravenski injekciji učinkovine pri povprečnem odraslem človeku (70kg).
These receptors are hyper-expressed by malignant tumours.
Ti receptorji so pretirano izraženi pri malignih tumorjih.
Any 99mTc-depreotide which remains in your body, will naturally lose its radioactivity within 2-3 days.
Ves v telesu preostali 99mTc- depreotid, bo izgubil svojo radioaktivnost po naravni poti v 2-3 dneh.
Dose calculations were performed using the standard MIRD method (MIRD Pamphlet No. 1 rev., Soc. Nucl.
Doza je izračunana po standardni MIRD metodi (MIRD Pamphlet No.1 rev., So.Nucl.
See Cautionary notes 1 and 2
Glejte spodaj Previdnostna opozorila, točka 1 in 2).
CAUTION: Do not allow the needle to touch the strip.
OPOZORILO: z iglo se ne smete dotakniti traku.
What NeoSpect looks like and contents of the pack
Izgled zdravila NeoSpect in vsebina pakiranja
Most frequently reported were headache, nausea, vomiting, diarrhoea, abdominal pain, dizziness, flushing and fatigue.
Najpogosteje so poročali o glavobolu, slabosti, bruhanju, driski, bolečini v trebuhu, omotici, rdečici in utrujenosti.
Like all medicines, NeoSpect can cause side effects, although not everybody gets them.
Kot vsa zdravila ima lahko tudi zdravilo NeoSpect neželene učinke, ki pa se ne pojavijo pri vseh bolnikih.
This solution is ready for injection into a vein.
Ta raztopina je pripravljena za injiciranje v veno.
The majority of the radioactivity excreted in urine is in parent form.
Večina radioaktivnosti se izloči z urinom v nespremenjeni obliki.
Familiarity with the practice and technique of resuscitation and treatment of anaphylaxis is essential.
Bistveno je dobro poznavanje postopkov in tehnik reševanja ter zdravljenja anafilaksije.
Care should also be taken to minimise radiation exposure to the patient, consistent with proper patient management.
Paziti moramo tudi, da je bolnik čim manj izpostavljen sevanju, v skladu s pravilnim obravnavanjem bolnika.
Observed changes in the laboratory parameters are: increased WBC count, basophils, eosinophils, monocytes and neutrophils, AST, ALT, LDH, total bilirubin and total protein; lowered RBC count and
Opažene spremembe laboratorijskih parametrov so: povečano število belih krvnih celic, bazofilcev, eozinofilcev, monocitov in nevtrofilcev, AST, ALT, LDH, celotni bilirubin in celotne beljakovine; znižano število rdečih krvnih celic in celotnih beljakovin.
Re-administration
Ponovna uporaba
Please read this leaflet carefully.
Natančno preberite to navodilo za uporabo.
Mark two Gelman ITLC-SG strips with a light pencil at 1 cm from the bottoms of each.
Dva Gelman ITLC-SG trakova označite s svetlim svinčnikom 1 cm od kraja.
Store in a freezer at or below -10 °C.
Shranjujte v zmrzovalniku pri ali pod -10°C.
The labelling reaction involved in the preparation of 99mTc-depreotide depends upon maintaining tin in the divalent (reduced) state.
Reakcija označevanja, ki poteka pri pripravi 99mTc depreotida je odvisna od vzdrževanja kositra v dvovalentni (reducirani) obliki.
99mTc-depreotide was not mutagenic in vitro in the Ames test or mouse lymphoma test, and it was not clastogenic in vivo in the mouse micronucleus test.
99mTc-depreotid ni bil mutagen in vitro v Amesovem testu ali mišjem limfomskem testu in ni bil klastogen in vivo v mišjem mikronukleusnem testu.
No studies on the effects on the ability to drive and use machines have been performed.
Študije o vplivu na sposobnost za vožnjo in upravljanje strojev niso bile opravljene.
If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor.
Če katerikoli neželeni učinek postane resen ali če opazite katerikoli neželeni učinek, ki ni omenjen v tem navodilu, obvestite svojega zdravnika.
NeoSpect is used to provide pictures which show the location of suspected malignant cancer tissue (a tumour) in the lung.
NeoSpect se uporablja za pridobitev slik, ki kažejo mesto suspektnega malignega rakastega tkiva (tumorja) v pljučih.
For scintigraphic imaging of suspected malignant tumours in the lung after initial detection, in combination with CT scan or chest X-ray, in patients with solitary pulmonary nodules.
Za scintigrafsko slikanje suspektnih malignih tumorjev v pljučih po začetnem odkritju, v kombinaciji z računalniško tomografijo (CT) ali rentgenskim slikanjem prsnega koša pri bolnikih s posameznimi
Care should be exercised in patients with reduced liver function.
Previdnost je potrebna pri bolnikih z zmanjšanim delovanjem jeter.
SPECIAL STORAGE CONDITIONS Store in a freezer at or below -10 °C.
POSEBNA NAVODILA ZA SHRANJEVANJE Shranjujte v zmrzovalniku pri ali pod - 10˚C.
It is essential that the user follows the directions carefully and adheres to aseptic procedures during the preparation of the radiopharmaceutical.
Bistveno je, da uporabnik natančno upošteva navodila in dosledno izvaja antiseptični postopek pri pripravi
White powder for solution for injection.
Bel prašek za raztopino za injiciranje
Do not use bacteriostatic sodium chloride solution for injection as a diluent for pertechnetate, because it might adversely affect the radiochemical purity and, hence, the biological distribution of the
Za redčenje pertehnetata ne uporabljajte raztopin natrijevega klorida za injiciranje, ki vsebujejo konzervans, ker lahko negativno vpliva na radiokemijsko čistost in s tem na biološko
Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product
Izdaja zdravila je le pod omejenimi pogoji in na recept (Glejte Dodatek I: Povzetek glavnih značilnosti
The activity of 99mTc-depreotide administered to the patient should be measured using a suitably calibrated dose calibrator immediately prior to administration to the patient.
Aktivnost 99mTc-depreotida za dajanje bolniku se mora meriti s pomočjo ustrezno kalibriranega kalibratorja doze neposredno pred dajanjem bolniku.
Radiolabelled NeoSpect is administered as a single injection into a vein.
Radioaktivno označen NeoSpect se daje kot enkratno injekcijo v veno.
Do not use if the solution is not clear or if it contains visible particulate matter.
Raztopine ne uporabljajte, če ni bistra ali vsebuje
Spot one drop (approximately 5-10 microlitres) of 99mTc-depreotide at the origin of each strip using the hypodermic needle.
Kanite kapljico (približno 5-10 mikrolitrov) 99mTc-depreotida na začetek vsakega traku z uporabo hipodermične igle.
Percent technetium-99m non-mobile material = A
Odstotni delež tehnecija-99m nemobilna faza = A
What NeoSpect is and what it is used for.
KAJ JE ZDRAVILO NeoSpect IN ZA KAJ GA UPORABLJAMO
The recommended dosage is approximately 47 micrograms depreotide (one vial) labelled with
Priporočeno odmerjanje je približno 47 mikrogramov depreotida (ena viala) označenega
The contents of the NeoSpect vial are sterile.
Vsebina NeoSpect vial je sterilna.
4.5 Interaction with other medicinal products and other forms of interaction
4.5 Medsebojno delovanje z drugimi zdravili in druge oblike interakcij Uradnih specifičnih študij medsebojnega delovanje z drugimi zdravili niso izvedli.
Most of the adverse reactions reported were transient and of mild intensity.
Večina neželenih učinkov o katerih so poročali, je bila prehodna in blage narave.
Plasma radioactivity is predominantly (>90%) in parent form, i.e. as 99mTc-depreotide.
Plazemska radioaktivnost je pretežno (90%) v nespremenjeni obliki, to je kot 99mTc-depreotid.
B. CONDITIONS OF THE MARKETING AUTHORISATION
B. POGOJI ZA DOVOLJENJE ZA PROMET Z ZDRAVILOM
Store the reconstituted solution for injection for no more than 5 hours at 15 °C - 25 °C using appropriate radiation shielding.
Rekonstituirano raztopino za injiciranje shranjujte do največ 5 ur pri 15°C - 25°C z uporabo ustreznega ščitnika proti sevanju.
Technetium (99mTc) depreotide solution for injection is a diagnostic radiopharmaceutical based upon a synthetic peptide that binds to somatostatin receptors.
Raztopina tehnecijevega (99mTc) depreotida za injiciranje je radiodiagnostik na osnovi sintetičnega peptida, ki se veže na somatostatinske receptorje.
The user should wear waterproof gloves and use shielding at all times when handling the reconstituted vial or syringes containing the radioactive agent.
Zdravstveno osebje mora nositi nepremočljive rokavice in ščitnik ves čas rokovanja z rekonstituiranimi vialami ali brizgami, ki vsebujejo radioaktivno
Prepare a boiling water bath containing a lead vial shield standing in and equilibrated with the boiling water bath.
Pripravite kopel z vrelo vodo v kateri stoji svinčeni ščitnik za vialo in je uravnotežen s kopeljo vrele vode.
Intravenous use
Za intravensko uporabo.
CAUTION: Do not allow the sides of the strip to contact the side of the tank.
OPOZORILO: Pazite, da se robovi traku ne dotaknejo stranic generatorja.
Place the second ITLC-SG strip in the SSCS developing solvent.
Postavite drugi ITLC-SG trak v SSCS topilo, ki se razvija.
Allow the vial kit to warm to 15 °C - 30 °C and place it in a suitable shielding container and sanitise the rubber septum with sanitising alcohol swab.
Pustite komplet z vialo, da se segreje na 15˚C-30˚C in ga namestite v primeren zaščitni vsebnik in očistite gumijasto pregrado s čistilno alkoholno blazinico.
May be prepared by adding about five grams of sodium chloride to the bottom of one chromatography chamber; add approximately 10 millilitres of distilled water to the solid sodium chloride and shake periodically during 10 to 15 minutes.
1) Nasičena raztopina natrijevega klorida (SSCS) Pripravi se jo lahko z dodajanjem 5 gramov natrijevega klorida na dno ene od kromatografskih komor; trdnemu natrijevemu kloridu dodajte približno 10 mililitrov destilirane vode in periodično stresajte 10 do 15 minut.
below) 1:1 (v/v) methanol / 1M ammonium acetate (MAM)2 (2 See section 2.)
1:1 (v/v) metanol/1M amonijev acetat (MAM)2(2Glejte točko 2.
Place one ITLC-SG strip in the MAM developing solvent.
Postavite eden ITLC-SG trak v MAM topilo, ki se razvija.
1:1 Methanol / 1M Ammonium Acetate (MAM) - Carefully mix one part methanol with one part 1M Ammonium Acetate.
1:1 metanol/1M amonijev acetate (MAM) - Previdno pomešajte en del metanola z enim delom 1M amonijevega acetate.
As with all injectable medicinal products, anaphylactic or anaphylactoid reactions may occur after administration.
Kot pri vseh zdravilih za injiciranje, se lahko po injiciranju pojavijo anafilaktične ali anafilaktoidne reakcije.
Most of the side effects reported were transient and of mild intensity.
Večina neželenih učinkov o katerih so poročali, je bila prehodnih in blage narave.
Sodium α-D-glucoheptonate dihydrate, stannous chloride dihydrate, disodium edetate, hydrochloric
Natrijev α-D-glukoheptonat dihidrat, kositrov (II) klorid dihidrat, dinatrijev edetat, klorovodikova
Pour the MAM and SSCS into separate developing tanks to a depth of approximately 0.5 cm. Cover the tanks and allow to equilibrate with the solvent vapours.
Natočite MAM in SSCD v dva ločena generatorja za razvijanje do globine približno 0,5 cm. Pokrijte in počakajte, da se uravnotežijo pare topila.
In a recent clinical study with a prevalence of malignancy of 49%, the positive predictive value for NeoSpect in association with CT/chest X-ray was 84% (CI 63.1-94.7%) for all SPNs and 81.8% for lesions equal to or less than 3cm.
V nedavni klinični šudiji s prevalenco malignosti 49%, je bila pozitivna napovedna vrednost za NeoSpect v povezavi s CT/ rentgenom prsnega koša 84% (IZ 63,1-94,7) za vse SPN in 81,8% za lezije enake ali manjše od 3 cm.
Manufacturer responsible for batch release:
Izdelovalec odgovoren za sproščanje serij:
In the pivotal studies, the negative predictive value for NeoSpect in association with CT for solitary pulmonary nodules (SPNs) was 90-96% at a disease prevalence of 30-50%.
V študijah je bila negativna napovedna vrednost za NeoSpect v povezavi z CT za posamezne pljučne vozliče(SPN) 90-96% pri 30- 50% prevalenci bolezni.
The contents of NeoSpect are intended only for use in the preparation of 99mTc-depreotide solution for injection (see section 12).
Vsebina NeoSpecta je namenjena za uporabo samo pripravljena z raztopino 99mTc-depreotida za injiciranje (glejte poglavje 12).
4.7 Effects on ability to drive and use machines No studies on the effects on the ability to drive and use machines have been performed.
Vpliv na sposobnost upravljanja vozil in uporabo strojev Študije o vplivu na sposobnost za vožnjo in upravljanje strojev niso bile opravljene.
Add approximately 15 ml of distilled water to the flask, stopper, and swirl to dissolve the solid.
Dodajte približno 15 ml destilirane vode v bučko, začepite in z vrtinčenjem raztapljajte trdno snov.
Due to the short, six-hour half-life of technetium-99m, less than 0.1% of the radioactivity remains
Zaradi kratkega, 6 urnega razpolovnega časa tehnecija-99m, ostane 60 ur po dajanju manj kot
Any oxidant present in the sodium pertechnetate (99mTc) solution for injection might adversely affect the quality of the preparation.
Prisotnost kateregakoli oksidanta v raztopini natrijevega pertehnetata (99mTc) za injiciranje lahko negativno vpliva na kvaliteto pripravka.
One 1 ml syringe and 21-gauge needle Suitable counting equipment
)spodaj) Eno 1 ml injekcijsko brizgo in 21 gauge iglo Primeren števec
It is not known whether 99mTc-depreotide is excreted in human milk, 99mTc-depreotide is therefore contraindicated during lactation.
Dojenje Ni znano, ali se 99mTc-depreotid pri človeku izloča z mlekom, zato je med dojenjem uporaba 99mTc depreotida kontraindicirana.
The binding affinity of 99mTc-depreotide to SSTR was shown in studies of pancreatic tumours in Lewis rats and in vitro in human tumour membranes.
Vezalna afiniteta 99mTc-depreotida za SSTR je bila dokazana v študijah tumorja trebušne slinavke pri Lewisovih podganah in in vitro na tumorskih membranah pri človeku.
Radionuclide procedures carried out on pregnant women also involve radiation doses to the foetus.
Pri radionuklidnem slikanju nosečnic dobi odmerek sevanja tudi plod.
ITLC-SG SSCS: cut the strip at Rf 0.75 (75% of the distance from the origin to the solvent
ITLC-SG MAM: odrežite trak pri Rf 0,40 (40% razdalje od začetka do linije topila) ITLC-SG SSCS: odrežite trak pri Rf 0,75 (75% razdalje od začetka do linije topila).
To minimise the dose of radiation absorbed by the bladder, adequate hydration should be encouraged to permit frequent voiding during the first few hours after injection.
Za zmanjševanje absorbirane doze ionizirajočega sevanja mehurja, je treba bolnika spodbuditi k primerni hidraciji, ki omogoča pogosto praznjenje mehurja v prvih urah po injekciji.
Kit for radiopharmaceutical preparation Depreotide
Komplet za pripravo radiofarmaka Depreotid
To minimise the dose of radiation absorbed by the bladder, the intake of fluids should be increased during the first few hours after injection to permit frequent voiding.
Za zmanjševanje absorbirane doze ionizirajočega sevanja, mehurja, morate povečati vnos tekočine prvih nekaj ur po injekciji, da omogočite pogosto praznjenje mehurja.
99mTc-depreotide is indicated for single use only.
99mTc-depreotid je namenjen samo za enkratno uporabo.
Percent technetium (99mTc) pertechnetate, technetium-99m labelled glucoheptonate and
Odstotni delež tehnecijevega (99mTc) pertehnetata, s tehnecijem-99m označenega glukoheptonata in s tehnecijem-99m označenega edetata = B
NeoSpect is supplied in packs of 1 vial and 5 vials, each vial containing 47 micrograms depreotide.
NeoSpect je pakiran v škatlah po 1 vialo in 5 vial, vsaka viala vsebuje 47 mikrogramov depreotida.
However, it is not considered likely that NeoSpect will affect your ability to drive or to operate
Vendar je pri NeoSpectu le malo verjetno, da bo vplival na vaše sposobnosti za upravljanje vozil in
After reconstitution, store at 15 °C - 25 °C and use within 5 hours.
Po rekonstituciji, shranjujte pri temperaturi med 15˚C -in 25˚C in uporabite v manj kot 5 urah.
Allow the solvent front to move to the top of the strip.
Počakajte, da topilo pripotuje do vrha traku.
NeoSpect is for diagnostic use only.
NeoSpect je samo za diagnostične namene.
Using a shielded syringe, inject the required radioactivity of up to 1.8 GBq of sodium pertechnetate (99mTc) solution for injection, (diluted as appropriate with sodium chloride 0.9%
Z uporabo brizge s ščitnikom, injicirajte zahtevano radioaktivnost do 1,8 GBq raztopine natrijevega pertehnetata (99mTc) za injiciranje, (ustrezno razredčene z 0,9 % m/v raztopino natrijevega klorida za injiciranje do skupno 1 ml) v vialo s ščitnikom.